Qa-2 mRNA in peripheral blood mononuclear cells: A potential marker of acute allograft rejection

Medical Science Monitor

Volumn 15, Issue 4, 2009, Pages

  Lu, Nan ^a,b   Wan, Furong ^a   Yang, Xiaojing ^a   Wang, Chuanxin ^a   Yi, Zhang ^a   Zhao, Shengmei ^a   Wang, Shenghua ^a   Li, Xiaoli ^a   Li, Xiangdong ^c   Zu, Mingchen ^a   Jiang, Hong ^d   Feng, Jinbo ^d   Zou, Xiong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d Qilu Hospital of Shandong University   (China)

Author keywords

Acute allograft rejection; Immunosuppressive treatment; Peripheral blood mononuclear cells; Qa 2

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 65949107553     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Alakulppi NS, Kyllonen LE, Partanen J et al: Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation, 2007, 83(6): 791-798
2. Mahmoud K, Opelz G, Pelzl S et al: Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection. Transplantation, 2007; 83(8): 1035-1040
3. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N: HLA-G: from biology to clinical benefits. Trends Immunol, 2008; 29(3): 125-132
4. Urosevic M, Dummer R: Human leukocyte antigen-G and cancer immunoediting. Cancer Res, 2008; 68(3): 627-630
5. Lila N, Amrein C, Guillemain R et al: Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant, 2007; 26(4): 421-422
6. Basturk B, Karakayali F, Emiroglu R et al: Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc, 2006; 38(2): 571-574
7. Qiu J, Terasaki PI, Miller J et al: Soluble HLA-G expression and renal graft acceptance. Am J Transplant, 2006; 6(9): 2152-2156
8. Creput C, Durrbach A, Menier C et al: Human leukocyte antigen-G (HLAG) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol, 2003; 39(4): 587-594
9. Rouas-Freiss N, LeMaoult J, Moreau P et al: HLA-G in transplantation: a relevant molecule for inhibition of graft rejection? Am J Transplant, 2003; 3(1): 11-16 (Pubitemid 36306817)
10. Lila N, Carpentier A, Amrein C et al: Implication of HLA-G molecule in heart-graft acceptance. Lancet, 2000; 355(9221): 2138
11. Creput C, Le FG, Bahri R et al: Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol, 2003; 64(11): 1033-1038
12. Luque J, Torres MI, Aumente MD et al: Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol, 2006; 67(4-5): 257-263
13. Rebmann V, Busemann A, Lindemann M, Grosse-Wilde H: Detection of HLA-G5 secreting cells. Hum Immunol, 2003; 64(11): 1017-1024
14. Comiskey M, Goldstein CY, De FS et al: Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product. Hum Immunol, 2003; 64(11): 999-1004 (Pubitemid 37413706)
15. Byrne MJ, Jones GS, Warner CM: Preimplantation embryo development (Ped) gene copy number varies from 0 to 85 in a population of wild mice identified as Mus musculus domesticus. Mamm Genome, 2007; 18(11): 767-778
16. Chiang EY, Stroynowski I: Protective immunity against disparate tumors is mediated by a nonpolymorphic MHC class I molecule. J Immunol, 2005; 174(9): 5367-5374
17. Watkins A, Wilkins A, Osmond C et al: The influence of mouse Ped gene expression on postnatal development. J Physiol, 2006; 571(Pt 1): 211-220
18. Cendales LC, Kirk AD, Moresi JM et al: Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation, 2006; 81(3): 418-422
19. Cheng O, Thuillier R, Sampson E et al: Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant, 2006; 6(10): 2292-2306
20. Susal C, Opelz G: Options for immunologic support of renal transplantation through the HLA and immunology laboratories. Am J Transplant, 2007; 7(6): 1450-1456
21. Sheshgiri R, Rao V, Tumiati LC et al: Soluble HLA-G is negatively associated with allograft rejection following heart transplantation. J Heart Lung Transpl, 2008; 27(Suppl. S(2)): 170
22. Sheshgiri R, Rouas-Freiss N, Rao V et al: Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant, 2008; 27(5): 522-527
23. Kaneku H: Detection of soluble HLA-G and its correlation with kidney transplant outcome. Clin Transpl, 2006; 447-454
24. Basturk B, Karakayali F, Emiroglu R et al: Human leukocyte antigen-G (HLA-G) a new parameter in the follow-up of liver transplantation. Tissue Antigens, 2006; 68(4): 355
25. Pistoia V, Morandi F, Wang X et al: Are they clinically relevant? Semin Cancer Biol, 2007; 17(6): 469-479
26. Rebmann V, LeMaoult J, Rouas-Freiss N et al: Quantification and identification of soluble HLA-G isoforms. Tissue Antigens, 2007; 69(Suppl.1): 143-149
27. Luque J, Torres MI, Aumente MD et al: sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transpl Immunol, 2006; 17(1): 70-73
28. Rizzo R, Melchiorri L, Simone L et al: Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool? Inflamm Bowel Dis, 2008; 14(1): 100-105
29. Gibson UE, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res, 1996; 6(10): 995-1001
30. Daniel V, Naujokat C, Sadeghi M et al: Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients. Transplantation, 2005; 79(11): 1498-1506 (Pubitemid 40847580)
31. Moreau P, Adrian-Cabestre F, Menier C et al: IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol, 1999; 11(5): 803-811
32. Riteau B, Rouas-Freiss N, Menier C et al: HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol, 2001; 166(8): 5018-5026 (Pubitemid 32280714)
33. + T cell regulatory mechanism. Proc Natl Acad Sci USA, 2001; 98(21): 12150-12155
34. Bahri R, Hirsch F, Josse A et al: Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol, 2006; 176(3): 1331-1339
35. Liang S, Baibakov B, Horuzsko A: HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol, 2002; 32(9): 2418-2426
36. Le RS, Azema C, Krawice-Radanne I et al: Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol, 2006; 176(5): 3266-3276
37. Wilczynski JR: Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? Hum Immunol, 2006; 67(7): 492-511
38. Sebti Y, Le MA, Gros F et al: Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol, 2007; 138(2): 202-212
39. Naji A, Durrbach A, Carosella ED, Rouas-Freiss N: Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. Hum Immunol, 2007; 68(4): 233-239
40. + cells by interacting with CD8. J Immunol, 2000; 164(12): 6100-6104